RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,040 | -85.4% | 2,264 | -78.2% | 0.00% | -75.0% |
| Q2 2023 | $130,147 | +175774.3% | 10,362 | +130.8% | 0.00% | +100.0% |
| Q1 2023 | $74 | -52.6% | 4,490 | -56.9% | 0.00% | -66.7% |
| Q4 2022 | $156 | -99.9% | 10,406 | +13.6% | 0.01% | +100.0% |
| Q3 2022 | $205,000 | -19.3% | 9,161 | -39.7% | 0.00% | -50.0% |
| Q2 2022 | $254,000 | +213.6% | 15,181 | +460.6% | 0.01% | +500.0% |
| Q1 2022 | $81,000 | -65.4% | 2,708 | -64.4% | 0.00% | -75.0% |
| Q4 2021 | $234,000 | -15.2% | 7,609 | -12.9% | 0.00% | -42.9% |
| Q3 2021 | $276,000 | +106.0% | 8,740 | +140.3% | 0.01% | +133.3% |
| Q2 2021 | $134,000 | +6.3% | 3,637 | -0.5% | 0.00% | +50.0% |
| Q1 2021 | $126,000 | -57.3% | 3,657 | -48.4% | 0.00% | -77.8% |
| Q4 2020 | $295,000 | +35.3% | 7,084 | +38.3% | 0.01% | +350.0% |
| Q3 2020 | $218,000 | – | 5,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |